We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$215M
AUM Growth
+$25.5M
Cap. Flow
+$7.11B
Cap. Flow %
3,306.68%
Top 10 Hldgs %
45.2%
Holding
253
New
155
Increased
83
Reduced
10
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Industrials 2.47%
3 Consumer Staples 1.65%
4 Financials 1.63%
5 Consumer Discretionary 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$122B
$958K 0.45%
26,130
-3,990
-13% -$198K
IGLD icon
52
FT Vest Gold Strategy Target Income ETF
IGLD
$500M
$929K 0.43%
+887,228
New +$17.4M
VZ icon
53
Verizon
VZ
$182B
$914K 0.43%
641,805
+633,762
+7,880% +$23.5M
IBM icon
54
IBM
IBM
$200B
$892K 0.41%
818,462
+811,180
+11,140% +$105M
PG icon
55
Procter & Gamble
PG
$349B
$868K 0.4%
583,761
+578,154
+10,311% +$87.1M
MMM icon
56
3M
MMM
$83.4B
$847K 0.39%
+967,937
New +$82.2M
NOC icon
57
Northrop Grumman
NOC
$74.1B
$847K 0.39%
721,792
+720,591
+59,999% +$327M
VWOB icon
58
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
$806K 0.37%
12,941
+210
+2% +$12.9K
VTIP icon
59
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$802K 0.37%
16,915
+483
+3% +$23K
FTCS icon
60
First Trust Capital Strength ETF
FTCS
$7.88B
$780K 0.36%
+749,475
New +$54.9M
AMZN icon
61
Amazon
AMZN
$2.66T
$740K 0.34%
98,818
+93,414
+1,729% +$10.7M
TRV icon
62
Travelers Companies
TRV
$78.5B
$735K 0.34%
692,624
+688,174
+15,465% +$121M
WMT icon
63
Walmart Inc
WMT
$909B
$731K 0.34%
1,833,060
+1,820,205
+14,160% +$91.8M
BA icon
64
Boeing
BA
$169B
$730K 0.34%
608,717
+605,196
+17,188% +$126M
CAT icon
65
Caterpillar
CAT
$405B
$706K 0.33%
664,167
+661,180
+22,135% +$147M
HON icon
66
Honeywell
HON
$71.3B
$674K 0.31%
666,302
+662,694
+18,367% +$123M
DOW icon
67
Dow Inc
DOW
$21.6B
$627K 0.29%
+541,268
New +$28.8M
INTC icon
68
Intel
INTC
$478B
$626K 0.29%
+587,122
New +$18.4M
USMV icon
69
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$588K 0.27%
+130,153
New +$9.51M
HYLB icon
70
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.51B
$560K 0.26%
39,739
+23,592
+146% +$809K
V icon
71
Visa
V
$682B
$550K 0.26%
348,694
+346,392
+15,047% +$79.3M
THLV icon
72
THOR Low Volatility ETF
THLV
$59.7M
$516K 0.24%
20,356
-416
-2% -$10.1K
XLY icon
73
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$513K 0.24%
1,005,392
+999,406
+16,696% +$76.5M
ADX icon
74
Adams Diversified Equity Fund
ADX
$3.18B
$480K 0.22%
28,549
+89
+0.3% +$1.42K
VXUS icon
75
Vanguard Total International Stock ETF
VXUS
$153B
$438K 0.2%
7,804
-49
-0.6% -$2.74K

Similar funds

Prostatis Group's Q2 2023 Portfolio in Review

As of Q2 2023, Prostatis Group held 253 positions worth $215M, up 13% from $189M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prostatis Group deployed $7.11B of net new capital in Q2 2023, opening 155 new positions and adding to 83 existing holdings. Its largest new stake was 3M: 967,937 shares worth $847K.

By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.4% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P Semiconductor ETF, an estimated $615K trimmed.

  • Prostatis Group's largest Q2 2023 buy was 3M: 967,937 shares worth $847K.
  • Prostatis Group added most to Thermo Fisher Scientific in Q2 2023, an estimated $782M increase.
  • Prostatis Group's biggest Q2 2023 reduction was State Street SPDR S&P Semiconductor ETF, cutting an estimated $615K.
  • Prostatis Group fully exited iShares US Healthcare Providers ETF in Q2 2023, selling an estimated $8.63M.
  • Prostatis Group's ten largest holdings make up 45% of its $215M portfolio in Q2 2023.
  • Prostatis Group opened 155 new positions and closed 3 in Q2 2023.
  • Prostatis Group's portfolio value rose 13% quarter-over-quarter to $215M.

Based on Prostatis Group's 13F filing for Q2 2023, filed 14 Aug 2023.